SPINEWAY overview

Press release Ecully, February 27, 2025 – 6.30 p.m. Spineway marks its return to Arab Health 2025 with new distribution agreements Spineway, a specialist in innovative implants for the treatment of severe spine disorders, took part in the 2025 edition of the Arab Health trade fair, which was held at the Dubai World Trade Centre from January 27 to 30, 2025. This unmissable event for the medical sector in the Middle East offered Spineway the chance to strengthen its presence in the region and...

Press release Ecully, December 18, 2024 – 6 p.m. Spineway wins new approvals in Vietnam and registers initial orders The Spineway Group, a specialist in innovative implants for the treatment of severe spine disorders, announces that it has obtained approvals for its ACIFBOX, VEOS, KAPHORN and TWIN PEAKS ranges in Vietnam. Following this approval, initial orders have been placed, confirming the growing interest in Spineway products in the region. These approvals will enable Spineway to meet the...

Press release Ecully, December 4, 2024 – 8 p.m. CET Spineway carries out a capital reduction by reducing the par value of its shares The Spineway Group, a specialist in innovative implants for the treatment of severe spine disorders, announces that the Board of Directors of Spineway (the “ Company ”) decided at its meeting of December 4, 2024, acting on a delegation of authority granted by the Combined General Meeting of March 25, 2024, under the terms of its twenty-third resolution, to...

Press release Ecully, October 15, 2024 – 6 p.m. SPINEWAY Continued organic growth Nine-month 2024 revenue of €9.1 million (+21%) In thousands of euros 2024 2023 Change % Q1 revenue 3,070 2,398 28% Q2 revenue 3,465 3,033 14% Q3 revenue 2,575 2,077 24% 9M revenue 9,110 7,510 21% Unaudited consolidated data The Spineway Group, a specialist in innovative implants for the treatment of severe spine disorders, recorded an excellent third quarter in 2024, with revenue of €2.6 million, representing...

SPINEWAY Half-year financial statements 2024 Attachment Consolidated financial statements – 06 30 2024...

SPINEWAY Half-year results 2024 Half-year turnover of €6.5 million (+20%) Improvement in operating income Full effect of savings measures visible in the 2nd half of 2024 In thousands of Euros Consolidated accounts S1 2024 S1 2023 Turnover 6 535 5 432 Cost of sales - 2 059 - 1 509 Gross margin % of turnover 4 476 68% 3 923 72% Net operating costs Of which operating costs - 5 246 - 2 232 - 5 556 -2 355 Of which personnel expenses - 2 685 - 2 978 Operating result - 770 - 1 256 Financial result Of...

Press release Ecully, September 12, 2024 – 6 p.m. SPINEWAY Great success at the 24th AMCICO Congress in Mexico Spineway , a specialist in innovative implants for the treatment of severe spine disorders, took part in the 24th AMCICO (Asociación Mexicana de Cirujanos de Columna) congress in Cancún from September 4 to 8, 2024. This annual congress of spine surgeons is a flagship event for the spine surgery sector in Mexico, the largest market in Central and Latin America. In partnership with...

Press release Ecully, July 24, 2024 – 6 p.m. Spineway a Gold Sponsor at the SILACO Congress in Mexico Organization of a special event with Latin American distributors The Spineway Group, a specialist in innovative implants for the treatment of severe spine disorders, is taking part in the Sociedad Iberolatinoamericana de Columna (SILACO) Congress in Mexico from July 24 to 27, 2024 with two local partners, Spinemed and Mava. As a Gold Sponsor of this major event in Latin America, Spineway will...